Evidence-Based Complementary and Alternative Medicine / 2020 / Article / Tab 3 / Review Article
The Effects and Safety of Chinese Oral Herbal Paste on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials Table 3 Assessment of risk of bias for included RCTs.
Author, year Random sequence generation Allocation concealment Blinding of participants and researchers Blinding of outcome assessment Incomplete outcome data Selective reporting Other bias Zhu et al. 2009 [24 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Zhang et al. 2013 [29 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Wang and Liu 2013 [30 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Chen et al. 2014 [31 ] Unclear risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Cheng et al. 2014 [32 ] Unclear risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Wang et al. 2014 [33 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Zhao et al. 2014 [34 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk He et al. 2015 [20 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Jiang et al. 2015 [22 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Wang et al. 2015 [35 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Wu et al. 2015 [36 ] Unclear risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Mao 2016 [37 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Zhang et al. 2017 [38 ] Unclear risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Zhao and Li 2017 [21 ] Unclear risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Deng et al. 2017 [39 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Luo 2017 [40 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk Rong and Ding 2017 [41 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Zhang 2018 [42 ] Low risk Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk Xia and Sun 2019 [23 ] Low risk Unclear risk High risk Unclear risk Low risk Low risk Unclear risk